Transgene(FR:TNG)
€0.73-0.03 (-3.58%)
FR:TNG
Transgene financials statements
€0.73
At close:-0.03 (-3.58%)
Want to see FR:TNG full AI Analyst Report?
Transgene (TNG) Financial Statements
8 Followers
Transgene Financial Overview
Transgene's market cap is currently €210.10M. The company's EPS TTM is €-0.17; its P/E ratio is -4.36; Transgene has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | € 490.00K | € 6.35M | € 7.90M | € 3.13M | € 9.99M |
| Gross Profit | € 490.00K | € -27.93M | € -21.69M | € -29.04M | € -22.89M |
| Operating Income | € -41.07M | € -35.66M | € -30.05M | € -29.90M | € -23.52M |
| EBITDA | € -39.77M | € -26.65M | € -28.44M | € -30.31M | € -16.55M |
| Net Income | € -37.52M | € -33.97M | € -22.33M | € -32.81M | € -20.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | € 111.86M | € 16.67M | € 15.67M | € 26.83M | € 49.57M |
| Total Assets | € 138.83M | € 42.17M | € 45.22M | € 66.44M | € 101.84M |
| Total Debt | € 2.06M | € 10.40M | € 1.35M | € 2.45M | € 3.84M |
| Net Debt | € -4.60M | € -6.44M | € -14.32M | € -1.95M | € -2.07M |
| Total Liabilities | € 17.09M | € 26.97M | € 29.61M | € 28.59M | € 34.63M |
| Stockholders' Equity | € 121.73M | € 15.20M | € 15.61M | € 37.84M | € 67.21M |
| Cash Flow | |||||
| Free Cash Flow | € -37.58M | € -26.62M | € -37.42M | € -21.84M | € -32.63M |
| Operating Cash Flow | € -36.74M | € -23.55M | € -34.67M | € -20.30M | € -31.94M |
| Investing Cash Flow | € -105.95M | € -3.21M | € 34.57M | € 20.27M | € 16.79M |
| Financing Cash Flow | € 134.38M | € 26.96M | € 11.37M | € -1.48M | € 15.77M |
Currency in EUR
